“r.itemList.length” “this.config.text.ariaShown”
“This.config.text.ariaFermé”
DUBLIN, 1 September 2020 / PRNewswire / – The report “European Market for Research Services by Healthcare Contract until 2027 – Type of Service; indication of healing; end-user and country “has been added to the ResearchAndMarkets.com offer.
The European market for physical care contract study organizations (CRO) is expected to succeed at USD 26094.15 million through 2027, up from USD 13,776.13 million in 2019.The market is expected to grow at a compound annual rate of 8.5% between 2020 and 2027.
The market expansion of physical care contract (CRT) organizations is basically attributed to the growing number of clinical trials and the increase in R
Clinical trials play a key role in drug approval and effectiveness in the disease.Studies to perceive the most productive medical approaches in safe healing areas.Health systems are seeing an immediate increase in the number of clinical trials.Factors such as development require state-of-the-art medicines and medical equipment, the increasing prevalence of chronic diseases and the expansion of investment systems for clinical trials are responsible for the increase in the number of clinical trials.
The control of these clinical trials requires extensive study facilities, committed resources and sufficient monetary needs.These clinical trial needs create a lucrative environment to prefer the organization of contract studies for the execution of clinical studies.In addition, corporations are focusing on partnering with contract.studies organizations for effective clinical studies.For example, Lipidor signed an agreement with Cadila Pharmaceuticals to conduct a phase III trial of the old candidate drug for psoriasis, AKP-02.organizations to conduct clinical studies, which will eventually stimulate market growth.
The pandemic effect of COVID-19 on cancer patients is superior in terms of fear, anxiety and mental anguish In Europe, many sponsors, collaborators or CRO, have announced interruptions in their planned and ongoing clinical trials in their SEC archives, press releases and clinical trial records, as well as on social media.Worldwide, 826 organizations reported on interrupted express clinical trials in the public domain, adding 8.2% in the UK, 5% in France and 3.7% in Switzerland.have an effect on the market for fitness care contract (CRO) study organisations in Europe.
Depending on the type of service, the market for physical care contract (CRT) study organizations is segmented into early-stage progression, laboratory matrix consulting, and clinical studies.The laboratory segment is also subdivided into bioanalytical and analytical tests. The clinical studies segment is divided into Phase I, Phase II, Phase III and Phase IV. In 2019, the clinical studies segment accounted for the largest percentage of the market.this segment is attributed to the increase in clinical trials and the increase in investment in R
Key topics
1. Introduction
1.1 Scope of the study
1.2 Report Guide
1.3 Market segmentation
2.Market for fitness care research organisations in Europe (CRO): key issues to remember
3. Research methodology
3.1 Coverage
3.2 Secondary investigation
3.3 Primary research
4.Health Care Contract Research Organizations (CRO) Services Market in Europe: Market Landscape
4.1 Summary
4.2 Pest analysis
4.2.1 Health Care Contract Research Organizations (CRO) Market – Pest Analysis in Europe
4.3 Expert opinion
5.European Healthcare Contract Research Organization (CRO) Services Market – Key Market Dynamics
5.1 Key market factors
5.1.1 Increase in R spending
5.1.1 Increasing number of trials
5.2 Key Market Restrictions
5.2.1 Strict regulations for drug approval
5.3 Key Market Opportunities
5.3.1 Increase in the market for biosimilars and biologics
5.4 Future Trends
5.4.1 Advancement of technology in research
5.5 Impact analysis
6.Health Care Contract Research Organization Services Market (CRS) – Europe Analysis
7.Market studies of fitness care research organisations in Europe (CRO) – by type of service
7.1 Summary
7.2 Market of study organizations under fitness care contract in Europe (CRO), by type of service 2019 and 2027 (%)
7.3 Initial phase development
7.4 Laboratory services
7.5 Consulting
7.6 Clinical research services
8.Analysis of the European Healthcare Contract Research Organization (CRO) services market: through therapeutic application
8.1 Summary
8.2 Market for services of research organizations under health contract in Europe (CRO), through therapeutic application 2019-2027 (%)
8.3 Oncology
8.4 Infectious diseases
8.5 Cardiovascular disease
8.6 Respiratory diseases
8.7 Neurological disorders
8.8 Others
9.Market studies of fitness care under-contract (CRO) research organisations – consistent with the end user
9.1 Summary
9.2 Market for research organizations under European healthcare contract services (CRO), consistent with end-user 2019-2027 (%)
9.3 Pharmaceutical and biopharmaceutical companies
9.4 Medical device companies
9.5 Other (university institutes)
Revenues and Market Forecasts for Health Care Contract Research Organizations (CRO) through 2027 – Geographic Analysis
11.Impact of the COVID-19 pandemic on the market of contract organisations in Europe (CRO)
12. Corporate profiles
12.1 ICON plc
12.2 IQVIA Inc.
12.3 Laboratory Corporation of America Holdings (Covance)
12.4 PRA Health Sciences
12.5 Syneos Health
For more information on this report, please visit
https://www.researchandmarkets.com/r/q0tjva
Reseek and Markets also offers custom searches that offer a targeted, complete and personalized search.
Media Contact:
Search and Markets Laura Wood, Senior Manager [email protected] For EST OFFICE hours, 1-917-300-0470 For the United States / CAN Call toll free 1-800-526-8630 For GMT OFFICE hours, 353- 1-416-8900 Fax US: 646-607-1907 Fax (except US): 353-1-481-1716
View content: http://www.prnewswire.com/news-releases/impact-of-covid-19-on-europes-healthcare-cro-services-market-2020-2027-301121882.html
SOURCE Research and Markets